Scharff P - Search Results

1

C₆₀ fullerene against SARS-CoV-2 coronavirus: an in silico insight.

Hurmach VV, Platonov MO, Prylutska SV, Scharff P, Prylutskyy YI, Ritter U. Hurmach VV, et al. Among authors: scharff p. Sci Rep. 2021 Sep 7;11(1):17748. doi: 10.1038/s41598-021-97268-6. Sci Rep. 2021. PMID: 34493768 Free PMC article.

2

Catalytic system of the reactive oxygen species on the C60 fullerene basis.

Burlaka AP, Sidorik YP, Prylutska SV, Matyshevska OP, Golub OA, Prylutskyy YI, Scharff P. Burlaka AP, et al. Among authors: scharff p. Exp Oncol. 2004 Dec;26(4):326-7. Exp Oncol. 2004. PMID: 15627068

3

Effect of the visible light irradiation of fullerene-containing composites on the ROS generation and the viability of tumor cells.

Prylutska SV, Burlaka AP, Matyshevska OP, Golub AA, Potebnya GP, Prylutskyy YI, Ritter U, Scharff P. Prylutska SV, et al. Among authors: scharff p. Exp Oncol. 2006 Jun;28(2):160-2. Exp Oncol. 2006. PMID: 16837910

4

Monte Carlo simulation of intercalated carbon nanotubes.

Mykhailenko O, Matsui D, Prylutskyy Y, Le Normand F, Eklund P, Scharff P. Mykhailenko O, et al. Among authors: scharff p. J Mol Model. 2007 Jan;13(1):283-7. doi: 10.1007/s00894-006-0129-8. Epub 2006 Oct 11. J Mol Model. 2007. PMID: 17033783

5

Therapeutic reactive oxygen generation.

Scharff P, Ritter U, Matyshevska OP, Prylutska SV, Grynyuk II, Golub AA, Prylutskyy YI, Burlaka AP. Scharff P, et al. Tumori. 2008 Mar-Apr;94(2):278-83. doi: 10.1177/030089160809400221. Tumori. 2008. PMID: 18564617

6

Hyperthermic effect of multi-walled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies.

Burlaka A, Lukin S, Prylutska S, Remeniak O, Prylutskyy Y, Shuba M, Maksimenko S, Ritter U, Scharff P. Burlaka A, et al. Among authors: scharff p. Exp Oncol. 2010 Mar;32(1):48-50. Exp Oncol. 2010. PMID: 20332757

7

Low-temperature 1H-NMR spectroscopic study of doxorubicin influence on the hydrated properties of nanosilica modified by DNA.

Turov VV, Chehun VF, Barvinchenko VN, Krupskaya TV, Prylutskyy YI, Scharff P, Ritter U. Turov VV, et al. Among authors: scharff p. J Mater Sci Mater Med. 2011 Mar;22(3):525-32. doi: 10.1007/s10856-011-4237-3. Epub 2011 Feb 2. J Mater Sci Mater Med. 2011. PMID: 21287246

8

Pristine C(60) fullerenes inhibit the rate of tumor growth and metastasis.

Prylutska SV, Burlaka AP, Prylutskyy YI, Ritter U, Scharff P. Prylutska SV, et al. Among authors: scharff p. Exp Oncol. 2011 Sep;33(3):162-4. Exp Oncol. 2011. PMID: 21956470

9

Effect of fullerene C60 on ATPase activity and superprecipitation of skeletal muscle actomyosin.

Andreichenko KS, Prylutska SV, Medynska KO, Bogutska KI, Nurishchenko NE, Prylutskyy YI, Ritter U, Scharff P. Andreichenko KS, et al. Among authors: scharff p. Ukr Biokhim Zh (1999). 2013 Mar-Apr;85(2):20-6. Ukr Biokhim Zh (1999). 2013. PMID: 23808306

10

Effect of iron-doped multi-walled carbon nanotubes on lipid model and cellular plasma membranes.

Prylutska S, Bilyy R, Schkandina T, Bychko A, Cherepanov V, Andreichenko K, Stoika R, Rybalchenko V, Prylutskyy Y, Scharff P, Ritter U. Prylutska S, et al. Among authors: scharff p. Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1486-9. doi: 10.1016/j.msec.2012.04.029. Epub 2012 Apr 24. Mater Sci Eng C Mater Biol Appl. 2012. PMID: 24364949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page